Get started
Author

Mark D. Berry

Observed names: M D Berry, M. Berry, M. D. Berry, M.D. Berry, Mark D Berry
Observed institutions: Roche (Switzerland), Skolkovo Institute of Science and Technology, Memorial University of Newfoundland, St Petersburg University, University of Saskatchewan, Brandon University, The Ohio State University
ORCID: 0000-0003-0172-0803
Observed ORCID: 0000-0003-0172-0803
OpenAlex ID: A5015490085
Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators
2004 · Mark D. Berry · Journal of Neurochemistry · 389
Trace Amines and Their Receptors
2018 · Raul R. Gainetdinov, Marius C. Hoener, et al. · Pharmacological Reviews · 386
Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges
2017 · Mark D. Berry, Raul R. Gainetdinov, et al. · Pharmacology & Therapeutics · 232
PDF
Apoptotic signaling cascades
2003 · Paula C. Ashe, Mark D. Berry · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 187
The functional role of monoamine oxidases A and B in the mammalian central nervous system
1994 · M.D. Berry, A.V. Juorio, et al. · Progress in Neurobiology · 180
The Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases
2007 · M. Berry · Reviews on Recent Clinical Trials · 132
Aromaticl-amino acid decarboxylase: A neglected and misunderstood enzyme
1996 · M. D. Berry, A. V. Juorio, et al. · Neurochemical Research · 129
Glyceraldehyde-3-phosphate dehydrogenase and apoptosis
2000 · M.D. Berry, A.A. Boulton · Journal of Neuroscience Research · 117
Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents
2001 · Paula C. Ashe, Mark D. Berry, et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 100
Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
1991 · I A Paterson, A V Juorio, et al. · Journal of Pharmacology and Experimental Therapeutics · 86
Trace Amine-Associated Receptors as Novel Therapeutic Targets for Immunomodulatory Disorders
2018 · Sherri L. Christian, Mark D. Berry · Frontiers in Pharmacology · 51
PDF
The effects of administration of monoamine oxidase‐B inhibitors on rat striatal neurone responses to dopamine
1994 · M.D. Berry, E. Scarr, et al. · British Journal of Pharmacology · 50
Possible mechanisms of action of (−)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders
1994 · M.D. Berry, A.V. Juorio, et al. · Progress in Neurobiology · 46
Membrane permeability of trace amines: Evidence for a regulated, activity-dependent, nonexocytotic, synaptic release
2013 · Mark D. Berry, Mithila R. Shitut, et al. · Synapse · 37
Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders
2004 · Mark D. Berry · Journal of Psychiatry and Neuroscience · 35
Phosphorylation and Activation of Brain Aromatic l ‐Amino Acid Decarboxylase by Cyclic AMP‐Dependent Protein Kinase
2000 · Anne‐Marie Duchemin, Mark D Berry, et al. · Journal of Neurochemistry · 35
TAAR1 Expression in Human Macrophages and Brain Tissue: A Potential Novel Facet of MS Neuroinflammation
2021 · David A. Barnes, Dylan A. Galloway, et al. · International Journal of Molecular Sciences · 34
PDF
The Use of Seahorse XF Assays to Interrogate Real-Time Energy Metabolism in Cancer Cell Lines
2022 · Jenna K. Caines, David A. Barnes, et al. · Methods in molecular biology · 33
Prolongation of Life in an Experimental Model of Aging in Drosophila Melanogaster
1999 · R.G. Jordens, M.D. Berry, et al. · Neurochemical Research · 26
Pharmacological characterization of a high-affinity p-tyramine transporter in rat brain synaptosomes
2016 · Mark D. Berry, Shannon Hart, et al. · Scientific Reports · 20
PDF
Identification of a subset of trace amine-associated receptors and ligands as potential modulators of insulin secretion
2019 · Michael J. Cripps, Marta Bagnati, et al. · Biochemical Pharmacology · 18
PDF
Aliphatic propargylamines as symptomatic and neuroprotective treatments for neurodegenerative diseases
2002 · M.D. Berry, A.A. Boulton · Neurotoxicology and Teratology · 18
Loss of mitochondrial membrane potential is dependent on the apoptotic program activated: Prevention by R-2HMP
1999 · D. Zhang, M.D. Berry, et al. · Journal of Neuroscience Research · 18
TAAR1 levels and sub-cellular distribution are cell line but not breast cancer subtype specific
2019 · Mallory S. Pitts, Josh N. McShane, et al. · Histochemistry and Cell Biology · 17
A Permeability Study of O2 and the Trace Amine p-Tyramine through Model Phosphatidylcholine Bilayers
2015 · Bryan W. Holland, Mark D. Berry, et al. · PLoS ONE · 14
PDF
Works count: 46
Citation count: 2,480
H-index: 20
I10-index: 26
Year
Topic
Type